Recruiting now—Ages 18 Years to 80 Years
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Sponsor: Northwestern University · NCT00005095 on ClinicalTrials.gov ↗
Conditions studied
Cervical CancerEndometrial CancerFallopian Tube CancerHereditary Breast/Ovarian Cancer (brca1, brca2)Ovarian CancerSarcomaUterine LeiomyomataVaginal CancerVulvar Cancer
What it tests
- Ca-125other
- screening questionnaire administrationother
- Surgeryprocedure
Where it's running1 site
- Recruiting now
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois 60611-3013
- Clinical Trials Office - Robert H. Lurie Comprehensive Cancer(contact)312-695-1301[email protected]
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
DISEASE CHARACTERISTICS:
* Meets one of the following criteria:
* Considered to be at increased risk for developing ovarian cancer, as defined by one of the following:
* Has at least one first-degree relative (mother, sister, or daughter) with ovarian, primary peritoneal, or fallopian tube cancer
* Has at least two first or second degree relatives diagnosed before age 50 with either ovarian, primary peritoneal, fallopian tube, and/or pancreatic cancer who have tested positive for hereditary cancer syndrome that includes an increased risk of gynecologic cancer (e.g., BRCA1/2 or Lynch Syndrome)or have increased risk as deemed by a certified genetic counselor
* A personal or family history of a hereditary cancer syndrome that includes an increased risk of gynecologic cancer
* Increased risk as deemed by a certified genetic counselor
* Undergoing surgery for a gynecologic condition, including any of the following:
* Diagnosis of a reproductive cancer
* Benign gynecological condition (e.g., uterine leiomyomata, endometriosis, pelvic inflammatory disease, or follicular or corpus luteum ovarian cysts)
* Highly suspicious adnexal mass
* Risk-reducing prophylactic oophorectomy
PATIENT CHARACTERISTICS:
Age
* Between the ages of 18 and 80Updated 2025-02-28 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.